Accurate measurement of droplet/particle deposition fraction and spatial distribution is vital for understanding various inhalation processes, including nebulized therapy, inhalation of atmospheric pollutants, and exposure risk assessment to aerosols such as airborne SARS-COV-2-laden droplets. This paper presents a novel method to measure the deposition fraction and spatial distribution of the deposited particulate phase (i.e., deposition pattern) of droplets through a single experiment. The experiment employs an idealized mouth-to-throat model as a test platform for two vibrating mesh nebulizers to deposit droplets. By utilizing a nebulized solution of normal saline containing the fluorescein, the qualitative observation of droplet deposition pattern on the internal surfaces is achieved under ultraviolet excitation. Furthermore, through rinsing the experimental components and quantitatively determining the deposition fraction based on rinsate absorbance, experimental results indicate that the deposition fraction of nebulized droplets decreases initially and then increases with increasing inspiratory flow rate from 15 to 60 l/min. Additionally, the deposition hotspots gradually shift from the bottom of the oral cavity to the throat as the inhalation flow rate increases. In addition to providing validation data for the transport and deposition of high-concentration droplets, this experimental method has the potential for extension to research on aerosol transmission and exposure risk assessment. It offers valuable insight into the behavior of nebulized droplets, aiding in developing effective strategies for aerosolized therapies and mitigating transmission risks in various applications.

The vibrating mesh nebulizer (VMN) has gained popularity for its compactness and noiselessness. This study investigates the impact of different air inlet structures on the deposition fraction (DF) of droplets generated by VMNs in an idealized mouth–throat (MT) airway model. Three homemade VMNs with semi-circular inlet, symmetrical four-inlet, and multiple-orifice inlet structures were evaluated through simulations and experiments. The changes in droplet DF of 0.9% w/v concentration of nebulized sodium chloride (NaCl) droplets as a function of inertial parameters were acquired under different inhalation flow conditions. Additionally, flow field distributions in models with different inlet structures were analyzed at a steady inspiratory flow rate of 15 L/min. The results indicate that optimizing the VMN’s air inlet structure significantly enhances droplet delivery efficiency. The multiple–orifice inlet structure outperformed the other designs, directing the airflow from the inlet position to the center of the mouthpiece and then into the oral cavity, achieving a DF of up to 20% at an inhalation flow rate of 15 L/min. The region of high airflow velocity between the mouthpiece and oral cavity proved to be a favorable VMN inlet optimization, reducing direct droplet–wall collisions and improving delivery efficiency. These findings offer insights for VMN design and optimization to enhance pulmonary drug delivery effectiveness and therapeutic outcomes.

The exchange of water vapor between high-concentration droplets and air significantly influences droplet deposition in the upper airway model during nebulizer use. This study employed a two-way coupled Eulerian–Lagrange method to quantify nebulized droplet evaporation and relative humidity (RH) variations within an idealized mouth–throat (MT) airway model, utilizing validated numerical models. The water vapor interaction between high-concentration droplets and inhaled air was computed using a multiplier based on the particle parcel method. Simulations of normal saline droplet flow inhalation in the MT airway were conducted under two environmental conditions: indoor (26.5 °C, RH = 50%) and warm and wet (30 °C, RH = 75%), with various inhalation flow rates mirroring previous experiments. Droplet deposition fractions (DFs) and deposition patterns were recorded. The results indicated that DF initially decreased and then increased with rising inhalation flow rates. The largest discrepancy between predicted and measured DFs was 10.86%. These findings support the theory that the balance between droplet evaporation and elevated air RH dictates the deposition of nebulized droplets in the airway. Additionally, simulations revealed that environmental conditions significantly affect droplet DF, with variations up to 20.78%. The deposition hotspot shifted from the anterior to the posterior pharynx.